mRNA Vaccine Nanoplatforms and Innate Immunity
mRNA-based vaccine technology has been significantly developed and enhanced, particularly highlighted by the authorization of mRNA vaccines for addressing the COVID-19 pandemic. Various biomaterials are developed in nano-scales and applied as mRNA vaccine delivery platforms. However, how these mRNA...
Main Authors: | Lai Wei, Chunhong Dong, Wandi Zhu, Bao-Zhong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/16/1/120 |
Similar Items
-
mRNA vaccine designs for optimal adjuvanticity and delivery
by: Yuki Mochida, et al.
Published: (2024-12-01) -
Innate and Adaptive Immune Parameters following mRNA Vaccination in Mice
by: Srinivasa Reddy Bonam, et al.
Published: (2024-05-01) -
Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines
by: Iman M. Alfagih, et al.
Published: (2020-12-01) -
RNA cancer vaccines: developing mRNA nanovaccine with self-adjuvant property for cancer immunotherapy
by: Hongxia Zhang, et al.
Published: (2021-09-01) -
cGAMP-adjuvanted multivalent influenza mRNA vaccines induce broadly protective immunity through cutaneous vaccination in mice
by: Wandi Zhu, et al.
Published: (2022-12-01)